drugset / Trial / NCT01517555

Effect of Liraglutide on Absorption of Paracetamol in Subjects With Type 2 Diabetes

NCT01517555

Phase 1 Completed 18 enrolled Novo Nordisk A/S
RandomizedCrossoverDouble-blindTreatment

Summary

This trial is conducted in Europe. The aim of this trial is to to investigate if there is a drug-drug interaction between liraglutide and paracetamol (Benuron®) and to investigate the effect of liraglutide on post prandial glucose.

Timeline

Start
2006-10
Primary completion
2007-05
Completion
2007-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 1 g Oral
Subject Liraglutide Peptide 1.8 mg Subcutaneous